The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme

Glioblastoma multiforme (GBM) represents the most common and aggressive malignant form of brain tumour in adults and is characterized by an extremely poor prognosis with dismal survival rates. Currently, expanding concepts concerning the pathophysiology of GBM are inextricably linked with neuroinfla...

Full description

Bibliographic Details
Main Authors: Łukasz A. Poniatowski, Michał Woźnica, Piotr Wojdasiewicz, Aneta Mela-Kalicka, Katarzyna Romanowska-Próchnicka, Daryush Purrahman, Grzegorz Żurek, Maciej Krawczyk, Najmeh Nameh Goshay Fard, Marzena Furtak-Niczyporuk, Janusz Jaroszyński, Mohammad-Reza Mahmoudian-Sani, Ilona Joniec-Maciejak
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/13/2/124
_version_ 1827369646121025536
author Łukasz A. Poniatowski
Michał Woźnica
Piotr Wojdasiewicz
Aneta Mela-Kalicka
Katarzyna Romanowska-Próchnicka
Daryush Purrahman
Grzegorz Żurek
Maciej Krawczyk
Najmeh Nameh Goshay Fard
Marzena Furtak-Niczyporuk
Janusz Jaroszyński
Mohammad-Reza Mahmoudian-Sani
Ilona Joniec-Maciejak
author_facet Łukasz A. Poniatowski
Michał Woźnica
Piotr Wojdasiewicz
Aneta Mela-Kalicka
Katarzyna Romanowska-Próchnicka
Daryush Purrahman
Grzegorz Żurek
Maciej Krawczyk
Najmeh Nameh Goshay Fard
Marzena Furtak-Niczyporuk
Janusz Jaroszyński
Mohammad-Reza Mahmoudian-Sani
Ilona Joniec-Maciejak
author_sort Łukasz A. Poniatowski
collection DOAJ
description Glioblastoma multiforme (GBM) represents the most common and aggressive malignant form of brain tumour in adults and is characterized by an extremely poor prognosis with dismal survival rates. Currently, expanding concepts concerning the pathophysiology of GBM are inextricably linked with neuroinflammatory phenomena. On account of this fact, the identification of novel pathomechanisms targeting neuroinflammation seems to be crucial in terms of yielding successful individual therapeutic strategies. In recent years, the pleiotropic growth factor progranulin (PGRN) has attracted significant attention in the neuroscience and oncological community regarding its neuroimmunomodulatory and oncogenic functions. This review of the literature summarizes and updates contemporary knowledge about PGRN, its associated receptors and signalling pathway involvement in GBM pathogenesis, indicating possible cellular and molecular mechanisms with potential diagnostic, prognostic and therapeutic targets in order to yield successful individual therapeutic strategies. After a review of the literature, we found that there are possible PGRN-targeted therapeutic approaches for implementation in GBM treatment algorithms both in preclinical and future clinical studies. Furthermore, PGRN-targeted therapies exerted their highest efficacy in combination with other established chemotherapeutic agents, such as temozolomide. The results of the analysis suggested that the possible implementation of routine determinations of PGRN and its associated receptors in tumour tissue and biofluids could serve as a diagnostic and prognostic biomarker of GBM. Furthermore, promising preclinical applications of PGRN-related findings should be investigated in clinical studies in order to create new diagnostic and therapeutic algorithms for GBM treatment.
first_indexed 2024-03-08T09:55:29Z
format Article
id doaj.art-0af7c7a5c01447f3b0c0a1e865db3584
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-08T09:55:29Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-0af7c7a5c01447f3b0c0a1e865db35842024-01-29T13:50:11ZengMDPI AGCells2073-44092024-01-0113212410.3390/cells13020124The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma MultiformeŁukasz A. Poniatowski0Michał Woźnica1Piotr Wojdasiewicz2Aneta Mela-Kalicka3Katarzyna Romanowska-Próchnicka4Daryush Purrahman5Grzegorz Żurek6Maciej Krawczyk7Najmeh Nameh Goshay Fard8Marzena Furtak-Niczyporuk9Janusz Jaroszyński10Mohammad-Reza Mahmoudian-Sani11Ilona Joniec-Maciejak12Department of Neurosurgery, Dietrich-Bonhoeffer-Klinikum, Salvador-Allende-Straße 30, 17036 Neubrandenburg, GermanyDepartment of Spine Surgery, 7th Navy Hospital, Polanki 117, 80-305 Gdańsk, PolandDepartment of Biophysics, Physiology and Pathophysiology, Faculty of Health Sciences, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, PolandDepartment of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology (CePT), Medical University of Warsaw, Banacha 1B, 02-097 Warsaw, PolandDepartment of Biophysics, Physiology and Pathophysiology, Faculty of Health Sciences, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, PolandThalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranDepartment of Biostructure, Wrocław University of Health and Sport Sciences, I. J. Paderewskiego 35, 51-612 Wrocław, Poland2nd Department of Neurology, Institute of Psychiatry and Neurology, Sobieskiego 9, 02-957 Warsaw, PolandThalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranDepartment of Public Health, Faculty of Medicine, Medical University of Lublin, Chodźki 1, 20-093 Lublin, PolandDepartment of Administrative Proceedings, Faculty of Law and Administration, Maria Curie-Skłodowska University of Lublin, Marii Curie-Skłodowskiej 5, 20-031 Lublin, PolandThalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranDepartment of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology (CePT), Medical University of Warsaw, Banacha 1B, 02-097 Warsaw, PolandGlioblastoma multiforme (GBM) represents the most common and aggressive malignant form of brain tumour in adults and is characterized by an extremely poor prognosis with dismal survival rates. Currently, expanding concepts concerning the pathophysiology of GBM are inextricably linked with neuroinflammatory phenomena. On account of this fact, the identification of novel pathomechanisms targeting neuroinflammation seems to be crucial in terms of yielding successful individual therapeutic strategies. In recent years, the pleiotropic growth factor progranulin (PGRN) has attracted significant attention in the neuroscience and oncological community regarding its neuroimmunomodulatory and oncogenic functions. This review of the literature summarizes and updates contemporary knowledge about PGRN, its associated receptors and signalling pathway involvement in GBM pathogenesis, indicating possible cellular and molecular mechanisms with potential diagnostic, prognostic and therapeutic targets in order to yield successful individual therapeutic strategies. After a review of the literature, we found that there are possible PGRN-targeted therapeutic approaches for implementation in GBM treatment algorithms both in preclinical and future clinical studies. Furthermore, PGRN-targeted therapies exerted their highest efficacy in combination with other established chemotherapeutic agents, such as temozolomide. The results of the analysis suggested that the possible implementation of routine determinations of PGRN and its associated receptors in tumour tissue and biofluids could serve as a diagnostic and prognostic biomarker of GBM. Furthermore, promising preclinical applications of PGRN-related findings should be investigated in clinical studies in order to create new diagnostic and therapeutic algorithms for GBM treatment.https://www.mdpi.com/2073-4409/13/2/124progranulinglioblastoma multiformebrain tumouroncogenesisdrug resistancetemozolomide
spellingShingle Łukasz A. Poniatowski
Michał Woźnica
Piotr Wojdasiewicz
Aneta Mela-Kalicka
Katarzyna Romanowska-Próchnicka
Daryush Purrahman
Grzegorz Żurek
Maciej Krawczyk
Najmeh Nameh Goshay Fard
Marzena Furtak-Niczyporuk
Janusz Jaroszyński
Mohammad-Reza Mahmoudian-Sani
Ilona Joniec-Maciejak
The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme
Cells
progranulin
glioblastoma multiforme
brain tumour
oncogenesis
drug resistance
temozolomide
title The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme
title_full The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme
title_fullStr The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme
title_full_unstemmed The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme
title_short The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme
title_sort role of progranulin pgrn in the pathogenesis of glioblastoma multiforme
topic progranulin
glioblastoma multiforme
brain tumour
oncogenesis
drug resistance
temozolomide
url https://www.mdpi.com/2073-4409/13/2/124
work_keys_str_mv AT łukaszaponiatowski theroleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT michałwoznica theroleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT piotrwojdasiewicz theroleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT anetamelakalicka theroleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT katarzynaromanowskaprochnicka theroleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT daryushpurrahman theroleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT grzegorzzurek theroleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT maciejkrawczyk theroleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT najmehnamehgoshayfard theroleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT marzenafurtakniczyporuk theroleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT januszjaroszynski theroleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT mohammadrezamahmoudiansani theroleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT ilonajoniecmaciejak theroleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT łukaszaponiatowski roleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT michałwoznica roleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT piotrwojdasiewicz roleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT anetamelakalicka roleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT katarzynaromanowskaprochnicka roleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT daryushpurrahman roleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT grzegorzzurek roleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT maciejkrawczyk roleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT najmehnamehgoshayfard roleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT marzenafurtakniczyporuk roleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT januszjaroszynski roleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT mohammadrezamahmoudiansani roleofprogranulinpgrninthepathogenesisofglioblastomamultiforme
AT ilonajoniecmaciejak roleofprogranulinpgrninthepathogenesisofglioblastomamultiforme